cobas^{^®} VivoDx System

The cobas® vivoDx System is used for the rapid detection, identification and determination of antimicrobial susceptibility of live bacteria in laboratories and other healthcare settings. The system incorporates the innovative Smarticles technology, which, for the first time, combines the speed and simplicity of molecular diagnostics with phenotypic detection to deliver fast results. This rapid detection helps in staying ahead of the ever-evolving antibiotic-resistant bacteria, providing information that is critical for multi-drug resistant organisms (MDRO) surveillance and for assisting physicians in guiding antibiotic therapy.

Rapid phenotypic results

The Smarticles technology utilizes custom-designed DNA-delivery bioparticles for the detection of live bacteria through bioluminescence. It requires minimal preparation and provides results in hours instead of days when compared to growth-based identification and susceptibility test methods.

Learn more about Smarticles technology.

Flexible and easy workflow

Continuous load design allows both single-sample and multi-sample processing. The innovative test cartridge format reduces contamination risk and the need to monitor reagents.

Sample in, results out

Automated processing and result interpretation provides an efficient path to definitive answers.

Connectivity

LIS connectivity is available for the cobas^® vivoDx System. The system uses either ASTM or HL7 communication protocol.

cobas^® vivoDx System

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

Explore the system

Take a look at our cobas^® vivoDx System to stay ahead of ever-evolving multi-drug resistant bacteria.

Stay ahead of methicillin-resistant Staphylococcus aureus (MRSA) infections

MRSA infections are one of the major causes of hospital-acquired infections and are associated with a huge healthcare burden.¹ Rapid detection of infections is critical for tackling the MRSA crisis. Explore the cobas® vivoDx MRSA assay for fast phenotypic detection of MRSA.

Registration status

CE-IVD

FDA De Novo Approved (Class II)

Package inserts

Access package inserts through your country’s Roche Diagnostics Website.

Reference

Siddiqui AH, Koirala J. Methicillin-resistant Staphylococcus aureus. StatPearls Publishing LLC. 2019.

Assay menu

View full List

System features

Instrument Dimensions

Width:

641 mm (25.25 in)

Height:

486 mm (19.125 in)

Height with open lid:

820 mm (32.284 in)

Depth:

727 mm (28.625 in)

Weight:

68 kg (150 lb)
Performance Features

5-hour run time

Load 1–24 samples at a time

Minimum 36 results within 8-hour shift (throughput varies depending on assay)

No reagents on board
Software Features

Intuitive/easy to use

Standard reports

Customized report

LIS Connectivity

Configurable result acceptance & reporting
Workflow Features

Single test, ready-to-use cartridge

Clear sample tracking

Hands-off onboard automation

Width:	641 mm (25.25 in)
Height:	486 mm (19.125 in)
Height with open lid:	820 mm (32.284 in)
Depth:	727 mm (28.625 in)
Weight:	68 kg (150 lb)

5-hour run time
Load 1–24 samples at a time
Minimum 36 results within 8-hour shift (throughput varies depending on assay)
No reagents on board

Intuitive/easy to use
Standard reports
Customized report
LIS Connectivity
Configurable result acceptance & reporting

Single test, ready-to-use cartridge
Clear sample tracking
Hands-off onboard automation

cobas® VivoDx System